Skip to main content

Advertisement

SpringerLink
Log in

Suppression of mTOR signaling pathway promotes bone marrow mesenchymal stem cells differentiation into osteoblast in degenerative scoliosis: in vivo and in vitro

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

To investigate the role of mTOR signaling pathway in bone marrow mesenchymal stem cells (BMSCs) differentiation into osteoblast in degenerative scoliosis (DS). The rat model of DS was established. Thirty-two Sprague–Dawley (SD) rats were selected and divided into the normal control group, the positive control group (normal rats injected with rapamycin), the negative control group (DS rats injected with PBS) and the experiment group (DS rats injected with rapamycin). H&E staining was performed to observe the osteogenesis of scoliosis. The BMSCs were obtained and assigned into seven groups: the normal control group, the positive control group, the negative control group and 1.0/10.0/100.0/1000.0 nmol/L experiment groups. Flow cytometry was conducted to testify cell cycle. The mRNA and protein expressions of mTOR and osteoblastic differentiation markers were measured by qRT-PCR and western blotting. In vivo, compared with the negative control group, bone trabecular area and the number of differentiated bone cells were significantly increased in the experiment groups. In vitro, at 24 and 48 h after rapamycin treatment, compared with the negative control group, BMSCs at G0/G1 stage increased, but BMSCs at S stage decreased in the 1.0/10.0/100.0/1000.0 nmol/L experiment groups; the expressions of mTOR and p70-S6K1 proteins were reduced in the 1.0/10.0/100.0/1000.0 nmol/L experiment groups, while ALP activity, OC levels, calcium deposition, Co1-I protein expression and the mRNA expressions of OC and Co1-I were significantly increased. Suppression of mTOR signaling pathway by rapamycin could promote BMSCs differentiation into osteoblast in DS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Zheng J, Yang Y, Zhao K, Wang R (2015) Low expression of microRNA-143 is related to degenerative scoliosis possibly by regulation of cyclooxygenase-2 expression. Int J Clin Exp Med 8(3):4140–4145

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Zhu Y, Wang K, Wang B, Wang H, Jin Z, Zhu Z, Liu H (2015) Selection of proximal fusion level for degenerative scoliosis and the entailing proximal-related late complications. Int J Clin Exp Med 8(4):5731–5738

    PubMed  PubMed Central  Google Scholar 

  3. Kotwal S, Pumberger M, Hughes A, Girardi F (2011) Degenerative scoliosis: a review. HSS J 7(3):257–264

    Article  PubMed  PubMed Central  Google Scholar 

  4. Han S, Zhu Y, Wu Z, Zhang J, Qiu G (2013) The differently expressed proteins in MSCs of degenerative scoliosis. J Orthop Sci 18(6):885–892

    Article  CAS  PubMed  Google Scholar 

  5. Li D, Wang C, Chi C, Wang Y, Zhao J, Fang J, Pan J (2016) Bone marrow mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory reactions in macrophages and endothelial cells. Mediators Inflamm 2016:2631439

    PubMed  PubMed Central  Google Scholar 

  6. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274–293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12(1):21–35

    Article  CAS  PubMed  Google Scholar 

  8. Urbanska M, Gozdz A, Swiech LJ, Jaworski J (2012) Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. J Biol Chem 287(36):30240–30256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA (2011) Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol 13(4):384–392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Awasthi N, Yen PL, Schwarz MA, Schwarz RE (2012) The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer. J Cell Biochem 113(3):784–791

    Article  CAS  PubMed  Google Scholar 

  11. Huang X, Zeng Y, Wang X, Ma X, Li Q, Li N, Su H, Huang W (2016) FXR blocks the growth of liver cancer cells through inhibiting mTOR-s6K pathway. Biochem Biophys Res Commun 474(2):351–356

    Article  CAS  PubMed  Google Scholar 

  12. Zhang Z, Yang M, Wang Y, Wang L, Jin Z, Ding L, Zhang L, Zhang L, Jiang W, Gao G, Yang J, Lu B, Cao F, Hu T (2016) Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway. Cell Biol Int 40(6):671–685

    Article  CAS  PubMed  Google Scholar 

  13. Gharibi B, Farzadi S, Ghuman M, Hughes FJ (2014) Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells. Stem Cells 32(8):2256–2266

    Article  CAS  PubMed  Google Scholar 

  14. Yang C, Li Y, Zhao Y, Zhu X, Li M, Liu G (2016) Adult degenerative scoliosis: can cobb angle on a supine posteroanterior radiograph be used to predict the cobb angle in a standing position?. Medicine (Baltimore) 95(6):e2732

    Article  Google Scholar 

  15. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8(2):128–135

    Article  CAS  PubMed  Google Scholar 

  16. Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I, Nagy JA, Lin MI, Walsh K, Dvorak AM, Briscoe DM, Neeman M, Sessa WC, Dvorak HF, Benjamin LE (2006) Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 10(2):159–170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124(3):471–484

    Article  CAS  PubMed  Google Scholar 

  18. Kanno H, Ozawa H, Sekiguchi A, Yamaya S, Tateda S, Yahata K, Itoi E (2012) The role of mTOR signaling pathway in spinal cord injury. Cell Cycle 11(17):3175–3179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zheng N, Ding X, Jahan R (2014) Low concentration of rapamycin inhibits hemangioma endothelial cell proliferation, migration, and vascular tumor formation in mice. Curr Ther Res Clin Exp 76:99–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Russo E, Andreozzi F, Iuliano R, Dattilo V, Procopio T, Fiume G, Mimmi S, Perrotti N, Citraro R, Sesti G, Constanti A, De Sarro G (2014) Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release. Brain Behav Immun 42:157–168

    Article  CAS  PubMed  Google Scholar 

  21. Cho HJ, Park J, Lee HW, Lee YS, Kim JB (2004) Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 321(4):942–948

    Article  CAS  PubMed  Google Scholar 

  22. Vignot S, Faivre S, Aguirre D, Raymond E (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 16(4):525–537

    Article  CAS  PubMed  Google Scholar 

  23. Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and inflammation. Nature 469(7330):323–335

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Antonarakis ES, Carducci MA, Eisenberger MA (2010) Novel targeted therapeutics for metastatic castration-resistant prostate cancer. Cancer Lett 291(1):1–13

    Article  CAS  PubMed  Google Scholar 

  25. Brennan-Speranza TC, Conigrave AD (2015) Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism. Calcif Tissue Int 96(1):1–10

    Article  CAS  PubMed  Google Scholar 

  26. Sun H, Kim JK, Mortensen R, Mutyaba LP, Hankenson KD, Krebsbach PH (2013) Osteoblast-targeted suppression of PPARgamma increases osteogenesis through activation of mTOR signaling. Stem Cells 31(10):2183–2192

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the reviewers for their constructive comments.

Author information

Authors and Affiliations

  1. Department of Orthopaedics, Peking University First Hospital, Xishiku Street 8, Beijing, 100034, China

    Yu Wang, Xiao-Dong Yi & Chun-De Li

Authors
  1. Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-Dong Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun-De Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chun-De Li.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Yi, XD. & Li, CD. Suppression of mTOR signaling pathway promotes bone marrow mesenchymal stem cells differentiation into osteoblast in degenerative scoliosis: in vivo and in vitro. Mol Biol Rep 44, 129–137 (2017). https://doi.org/10.1007/s11033-016-4089-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-016-4089-5

Keywords

Search

Navigation